Suven Life Sciences

quarterly
yearly
ParticularsMar '25Jun '25Sep '25Dec '25Mar '26
Revenue2.692.474.705.588.30
Expenses46.6353.9882.01107.5153.90
EBITDA-42.59-50.15-75.99-100.57-43.86
Operating Profit-43.94-51.52-77.31-101.92-45.44
Profit Before Tax-43.94-51.52-77.31-101.92-45.60
Net Profit-43.94-51.52-77.31-101.92-45.60
Financial Ratios
Operating Profit Margin-2,898%-2,682%-8,260%-3,579%-2,886%
Net Profit Margin-2,989%-2,755%-8,403%-3,627%-3,000%
Earning Per Share (Diluted)-2.02-2.36-3.48-4.55-2.02
Dividends Per Share0.000.000.000.000.00